GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aptorum Group Ltd (NAS:APM) » Definitions » 1-Year ROIIC %

Aptorum Group (Aptorum Group) 1-Year ROIIC % : -50.23% (As of Jun. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Aptorum Group 1-Year ROIIC %?

1-Year Return on Invested Incremental Capital (1-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 1-year. Aptorum Group's 1-Year ROIIC % for the quarter that ended in Jun. 2023 was -50.23%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Aptorum Group's 1-Year ROIIC % or its related term are showing as below:

APM's 1-Year ROIIC % is ranked worse than
63.47% of 1462 companies
in the Biotechnology industry
Industry Median: -2.96 vs APM: -50.23

Aptorum Group 1-Year ROIIC % Historical Data

The historical data trend for Aptorum Group's 1-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aptorum Group 1-Year ROIIC % Chart

Aptorum Group Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
1-Year ROIIC %
Get a 7-Day Free Trial - 53.14 41.82 -64.96 15.85

Aptorum Group Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
1-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.37 -64.96 37.13 15.85 -50.23

Competitive Comparison of Aptorum Group's 1-Year ROIIC %

For the Biotechnology subindustry, Aptorum Group's 1-Year ROIIC %, along with its competitors' market caps and 1-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aptorum Group's 1-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aptorum Group's 1-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Aptorum Group's 1-Year ROIIC % falls into.



Aptorum Group 1-Year ROIIC % Calculation

Aptorum Group's 1-Year ROIIC % for the quarter that ended in Jun. 2023 is calculated as:

1-Year ROIIC %=1-Year Incremental Net Operating Profit After Taxes (NOPAT)**/1-Year Incremental Invested Capital
=( -15.597 (Jun. 2023) - -18.165 (Jun. 2022) )/( 12.944 (Jun. 2023) - 18.056 (Jun. 2022) )
=2.568/-5.112
=-50.23%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** TTM data of NOPAT and Invested Capital was used to calculate 1-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Aptorum Group  (NAS:APM) 1-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Aptorum Group 1-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Aptorum Group's 1-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aptorum Group (Aptorum Group) Business Description

Traded in Other Exchanges
N/A
Address
17 Hanover Square, London, GBR, W1S 1BN
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group (Aptorum Group) Headlines